Skip to main content

Table 3 Availability of biological drugsa

From: Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions

Country (n)b

Australia (13)

China,

Hong Kong (2)

China, Taiwan (4)

India (28)

Indonesia (4)

Laos (1)

Malaysia (198)

Myanmar (31)

Nepal (1)

New Zealand (2)

Pakistan (2)

The Philippines (2)

Singapore (3)

Thailand (44)

Vietnam (2)

Medication

Adalimumab

Etanercept

Golimumab

Infliximab

Anakinra

Canakinumab

Tocilizumab

Belimumab

Rituximab

Abatacept

Secukinumab

Tofacitinib

Ustekinumab

  1. aThe data obtained during the study period
  2. bThe number of responses per country, 3 missed